Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-26

Clinical Trial Update: Use of Tranexamic Acid in Facial Fillers [Phase 4]

View source ↗

Summary

Phase 4 trial exploring tranexamic acid for injection site bruising in facial fillers was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Injection Site Bruising | Phase 4 | Status: WITHDRAWN